))
Additional Advances in Immune Thrombocytopenia Research and Clinical Trials
Manage episode 357636649 series 3456244
İçerik i3 Health and I3 Health tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan i3 Health and I3 Health veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
In 2022, Allison Imahiyerobo, an Advanced Practice Nurse at the Englewood Health Physician Network in New Jersey, led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity with i3 Health, New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia. A year later, Ms. Imahiyerobo sat down with Oncology Data Advisor to discuss additional advancements and updates in ITP management and patient care since recording. Click here to view and claim credit for New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia, an accredited CME/NCPD activity provided by i3 Health: https://i3health.com/patient-outcomes-itp
…
continue reading
30 bölüm
Paylaş
